Clinical Trials

120 enrolled

Multiple Myeloma, Recurrence

NCT07280013 2026-04-17

A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects

60 enrolled

Bites and Stings, Multiple Myeloma, Recurrence

NCT05675449 2026-04-13

MagnetisMM-20

59 enrolled

Multiple Myeloma, Recurrence

NCT06425991 2026-04-13

MajesTEC-10

108 enrolled

Multiple Myeloma, Recurrence

NCT04684108 2026-04-07

SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies

Other hematologic neoplasmPlasma cell

61 enrolled

Multiple Myeloma, Recurrence, Hematologic Neoplasms

NCT04756726 2026-03-25

Study to Assess the Safety and Tolerability of CFT7455 in Relapsed/Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma

224 enrolled

Lymphoma, Non-Hodgkin, Multiple Myeloma, Recurrence

NCT06375044 2026-03-06

Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma

130 enrolled

Multiple Myeloma, Recurrence

NCT06325748 2026-02-12

SENTI-202: Off-the-shelf Logic Gated CAR NK Cell Therapy in Adults With CD33 and/or FLT3 Blood Cancers Including AML/MDS

MyeloidOther hematologic neoplasmPlasma cell

21 enrolled

Blastic Plasmacytoid Dendritic Cell Neoplasm, Multiple Myeloma, Recurrence, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute

NCT04155749 2026-02-11

Study of Anitocabtagene-autoleucel in Participants With Relapsed Refractory Multiple Myeloma

40 enrolled

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT07105059 2026-02-09

A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma

Multiple Myeloma, Recurrence

NCT06574568 2026-02-05

A Study of YKST02 in Participants With Relapsed or Refractory Multiple Myeloma

70 enrolled

Multiple Myeloma, Recurrence

NCT07369895 2026-01-27

Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma

Multiple Myeloma, Recurrence

NCT01562405 2026-01-14

Sotatercept (ACE-011) With Lenalidomide or Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma

33 enrolled

Multiple Myeloma, Recurrence

NCT04398680 2025-12-04

DREAMM 13

Phase 1 Withdrawn

Multiple Myeloma, Recurrence

NCT07003555 2025-11-26

Dual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration

Multiple Myeloma, Recurrence

NCT07003568 2025-11-26

Dual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration

Multiple Myeloma, Recurrence

NCT06304636 2025-11-24

DC15-MM-01

4 enrolled

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT06381141 2025-09-18

A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma

30 enrolled

Multiple Myeloma, Recurrence

NCT05913804 2025-08-15

YTS104 Cell Injection for the Treatment of Relapsed or Refractory Multiple Myeloma

12 enrolled

Phase 1 Not yet recruiting

Multiple Myeloma, Recurrence

NCT07113496 2025-08-13

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

27 enrolled

Plasmablastic Lymphoma, Burkitt Lymphoma, Multiple Myeloma, Recurrence

NCT05011097 2025-07-20

A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma

20 enrolled

Multiple Myeloma, Recurrence

NCT02675452 2025-07-09

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

Other hematologic neoplasmPlasma cell

141 enrolled 46 charts

Multiple Myeloma, Recurrence, Leukemia, Myeloid, Acute

NCT02332850 2025-05-01

Phase Ib Study of SAR650984 in Combination With Carfilzomib for Treatment of Relapsed or Refractory Multiple Myeloma

83 enrolled

Multiple Myeloma, Recurrence

NCT03486067 2025-04-17

Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multiple Myeloma

183 enrolled

Multiple Myeloma, Recurrence

NCT04975399 2025-03-24

Study to Evaluate the Safety and Tolerability of CC-92328 in Participants With Relapsed and/or Refractory Multiple Myeloma

26 enrolled

Multiple Myeloma, Recurrence

NCT05227144 2025-03-20

Study of ORIC-533 in Relapsed or Refractory Multiple Myeloma

31 enrolled

Multiple Myeloma, Recurrence

NCT02245867 2025-02-07

Study of Chimeric Fibril-Reactive Monoclonal Antibody 11-1F4 in Patients With AL Amyloidosis

30 enrolled

Immunoglobulin Light-chain Amyloidosis, Recurrence

NCT04887259 2025-01-27

Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML

LymphoidOther hematologic neoplasmPlasma cell

16 enrolled

Multiple Myeloma, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute

NCT02043847 2024-11-13

BMT-03

12 enrolled 12 charts

Multiple Myeloma, Recurrence, Disease Progression

NCT03755154 2024-10-16

Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia

LymphoidOther hematologic neoplasmPlasma cell

60 enrolled

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Neoplasms, Plasma Cell

NCT03710915 2024-10-10

A Study of HG146 Capsule in Chinese Subjects with Relapsed and Refractory Multiple Myeloma

3 enrolled

Multiple Myeloma, Recurrence

NCT04798586 2024-09-27

MAGNETISMM-2: Study of Elranatamab (PF-06863135) in Japanese Participants With Multiple Myeloma

4 enrolled 19 charts

Multiple Myeloma, Recurrence

NCT02099539 2024-09-26

QUILT-3.005: A Study of N-803 in Patients With Relapsed or Refractory Multiple Myeloma

19 enrolled 22 charts

Multiple Myeloma, Neoplasms, Recurrence

NCT02939183 2024-09-26

INTREPID-1

61 enrolled 28 charts

Multiple Myeloma, Recurrence

NCT02616640 2024-09-19

A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Without Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma

114 enrolled

Multiple Myeloma, Recurrence

NCT02978235 2024-09-05

A Dose Finding Study Followed by a Safety and Efficacy Study for Patients With Multiple Myeloma or Lymphoma

11 enrolled

Hematologic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Lymphoma, Mantle-Cell, Neoplasms, Plasma Cell

NCT04036461 2024-08-30

A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma

47 enrolled

Phase 1 Not yet recruiting

Multiple Myeloma, Recurrence

NCT06500507 2024-07-15

A Study of QLS4131 in Patients With Recurrent or Refractory Multiple Myeloma

90 enrolled

Multiple Myeloma, Recurrence

NCT05641324 2024-02-12

A Study of ANV419 Alone or in Combination With Approved Treatments in Patients With Multiple Myeloma (OMNIA-2)

4 enrolled

Disease, Hematologic Diseases, Multiple Myeloma, Neoplasms, Recurrence

NCT06084962 2023-10-16

A Study of DeepTag-GPRC5D Targeted CAR-T Cells Therapy for Refractory/Relapsed Multiple Myeloma

40 enrolled

Multiple Myeloma, Recurrence

NCT06082596 2023-10-13

Study of BEBT-908 in Subjects With Advanced Hematological Tumors

32 enrolled

Lymphoma, Non-Hodgkin, Multiple Myeloma, Recurrence

NCT04613557 2023-08-31

IMMUNICY-1

Multiple Myeloma, Recurrence

NCT05918250 2023-08-18

mRNA-2736 for Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Phase 1 Withdrawn

Multiple Myeloma, Recurrence

NCT04214093 2023-08-02

A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors

LymphoidOther hematologic neoplasmPlasma cell

9 enrolled

Lymphoma, Multiple Myeloma, Recurrence, Tumor Lysis Syndrome, Hematologic Neoplasms

NCT05920876 2023-06-27

A Study of QLS32015 in Patients With Recurrent or Refractory Multiple Myeloma

Phase 1 Unknown

100 enrolled

Multiple Myeloma, Recurrence

NCT04136756 2023-06-15

NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin Lymphoma

30 enrolled